|
2025
|
P/S
|
Non-medicated toilet preparations and skin care products; cosmetic and beauty preparations; cosme... |
|
|
P/S
|
Non-medicated toilet preparations and skin care products, cosmetic and beauty preparations, cosme... |
|
|
P/S
|
Downloadable mobile application for patient education and training in the use and administration ... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Foot deodorant spray; Non-medicated foot lotions; Antiperspirants; Cosmetic preparations |
|
|
P/S
|
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep... |
|
|
P/S
|
Pharmaceutical, medical and veterinary preparations, sanitary preparations for medical purposes, ... |
|
|
P/S
|
Downloadable software in the nature of a mobile application for providing information related to ... |
|
|
P/S
|
Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à sa... |
|
|
P/S
|
Downloadable podcasts in the field of breast cancer diagnosis, treatment and management Entertain... |
|
|
Invention
|
Methods of treating sjogren's syndrome using a bruton's tyrosine kinase inhibitor.
The present d... |
|
|
Invention
|
Method of treating prostate cancer.
The present disclosure relates to a method of treating prost... |
|
|
Invention
|
Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1h-cyclopenta[b]pyridine-3-carboxyl... |
|
|
P/S
|
Providing a website featuring information in the field of the diagnosis and treatment of breast c... |
|
|
P/S
|
Downloadable software for healthcare professionals for the
provision of information about radiol... |
|
|
Invention
|
Stable, concentrated radiopharmaceutical composition.
The present disclosure relates to radionuc... |
|
|
Invention
|
Treatment of cancer using a cd33 chimeric antigen receptor.
The invention provides compositions ... |
|
|
Invention
|
Regimens and methods of treating multiple sclerosis using ofatumumab.
The disclosure is directed... |
|
|
Invention
|
Dosing regimens for n-(3-cyano-5-(cyclohexylmethyl)-6,6-dimethyl-4,5,6,7-tetrahydrothieno[3,2-c]p... |
|
|
Invention
|
Antiviral pyrazolopyridinone compounds.
The invention provides compounds of Formula (I)
The in... |
|
|
Invention
|
Molecular glue degrader compounds and uses thereof. Described herein are molecular glue degrader ... |
|
|
Invention
|
Pharmaceutical formulations of an androgen receptor-targeting protein degrader. The present discl... |
|
|
Invention
|
Pharmaceutical formulations of an androgen receptor-targeting protein degrader.
The present disc... |
|
|
Invention
|
Her2 targeting cyclic peptides and conjugates thereof.
Described herein are cyclic peptides targ... |
|
|
Invention
|
Her2 targeting cyclic peptides and conjugates thereof. Described herein are cyclic peptides targe... |
|
|
Invention
|
Pharmaceutical compositions of ribociclib. Pharmaceutical compositions of ribociclib ora pharmace... |
|
|
Invention
|
Pharmaceutical compositions of ribociclib.
Pharmaceutical compositions of ribociclib or a pharma... |
|
|
Invention
|
Macrocyclic panras inhibitors for the treatment of cancer. The present invention relates to compo... |
|
|
Invention
|
Combination therapy for the treatment of cancer comprising a wrn inhibitor, radiation therapy, ca... |
|
|
Invention
|
177lu]lu-psma-617. Described herein are combination therapies featuring [177Lu]Lu-PSMA-617 and a ... |
|
|
Invention
|
Process of preparing remibrutinib substantially free of nitrosamine impurity. NNNN-(3-(6-amino-5-... |
|
|
Invention
|
Process of preparing remibrutinib substantially free of nitrosamine impurity.
This invention rel... |
|
|
Invention
|
Kras g12c inhibitor for use for the treatment of non-small cell lung cancer. The present inventio... |
|
|
Invention
|
Pharmaceutical products and stable liquid compositions of il-17 antibodies.
The disclosure is di... |
|
|
Invention
|
Method for measuring flow features in an inhaler, inhaler and system.
The present invention rela... |
|
|
Invention
|
3-(1-oxo-5-(piperidin-4-yl)isoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof.
Th... |
|
|
Invention
|
Cell-based assay for measuring drug product potency.
The invention relates to the an in vitro qu... |
|
|
Invention
|
Mesothelin chimeric antigen receptor (car) and antibody against pd-l1 inhibitor for combined use ... |
|
|
Invention
|
Methods and compositions for treatment of cartilage damage and arthritis.
The invention provides... |
|
2024
|
Invention
|
Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-... |
|
|
Invention
|
Shp inhibitor compositions and uses for chimeric antigen receptor therapy.
Compositions and meth... |
|
|
Invention
|
Use of a combination of sacubitril and valsartan.
The present invention relates to methods and p... |
|
|
Invention
|
Injection device and injection solution transferring system.
An Injection device (10) comprises ... |
|
|
Invention
|
New crystalline forms of salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[... |
|
|
Invention
|
Pyrazolopyridine derivatives and uses thereof.
The present disclosure relates to compounds of fo... |
|
|
Invention
|
Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules.... |
|
|
Invention
|
Rapcabtagene autoleucel for use in treating systemic lupus erythematosus. The invention provides ... |
|
2023
|
Invention
|
Medical autoinjector device |
|
|
Invention
|
Crystalline forms of an akric3 dependent kars inhibitor.
This application relates to crystalline... |
|
|
Invention
|
Pharmaceutical compositions of tricyclic akr1c3 dependent kars inhibitor and methods for making s... |
|
|
Invention
|
(s)-engineered oxynitrilase polypeptides and uses thereof.
The present disclosure relates to a p... |
|
|
Invention
|
Met bcl-xl inhibitor antibody-drug conjugates and methods of use thereof.
Anti-Met antibody-drug... |
|
|
Invention
|
Piperidinyl-methyl-purine amine salts, crystalline forms, and their use in treating medical disea... |
|
|
Invention
|
Improved protein production using mirna technology.
The present invention pertains to the use of... |
|
|
Invention
|
Methods of treating giant cell arteritis using interleukin-17 (il-17) antagonists.
The present d... |
|
|
Invention
|
Novel recombinant aav vp2 fusion polypeptides.
This disclosure relates to adeno-associated virus... |
|
|
Invention
|
Dosage regimens for anti-cd19 agents and uses thereof.
The present disclosure relates to dosage ... |
|
2022
|
Invention
|
Treatment of allergic reactions using anti-ige antibodies.
The present disclosure relates to met... |
|
|
Invention
|
Surfactant stabilizers.
The present invention is directed to stabilized protein-containing formu... |
|
|
Invention
|
Pharmaceutical composition.
The present invention relates to the field of pharmacy, particularly... |
|
2021
|
Invention
|
Expression technology for antibody constructs.
The present invention pertains to expression vect... |
